Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry-Reference-Cited by-同舟云学术

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

Published:2019-12-12 Issue:24 Volume:134 Page:2159-2170
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Amador Catalina¹^ORCID,Greiner Timothy C.¹^ORCID,Heavican Tayla B.¹,Smith Lynette M.²^ORCID,Galvis Karen Tatiana¹³,Lone Waseem¹,Bouska Alyssa¹,D’Amore Francesco⁴^ORCID,Pedersen Martin Bjerregaard⁴^ORCID,Pileri Stefano⁵⁶^ORCID,Agostinelli Claudio⁶^ORCID,Feldman Andrew L.⁷^ORCID,Rosenwald Andreas⁸⁹,Ott German¹⁰¹¹,Mottok Anja¹²¹³,Savage Kerry J.¹²,de Leval Laurence¹⁴,Gaulard Philippe¹⁵,Lim Soon Thye¹⁶^ORCID,Ong Choon Kiat¹⁶^ORCID,Ondrejka Sarah L.¹⁷,Song Joo¹⁸,Campo Elias¹⁹²⁰^ORCID,Jaffe Elaine S.²¹^ORCID,Staudt Louis M.²²,Rimsza Lisa M.²³,Vose Julie²⁴^ORCID,Weisenburger Dennis D.¹⁸,Chan Wing C.¹⁸,Iqbal Javeed¹

Affiliation:

1. Department of Pathology and Microbiology and

2. Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE;

3. Department of Pathology and Laboratory Medicine, Fundacion Santa Fe de Bogota University Hospital, Bogota, Colombia;

4. Department of Hematology, Aarhus University Hospital, Aarhus, Denmark;

5. European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;

6. Department of Specialized, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy;

7. Department of Laboratory Medicine and Pathology, College of Medicine, Mayo Clinic, Rochester, MN;

8. Institute of Pathology and

9. Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany;

10. Department of Clinical Pathology and

11. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Robert-Bosch-Krankenhaus, Stuttgart, Germany;

12. Center for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;

13. Institute of Human Genetics, Ulm University/University Medical Centre, Ulm, Germany;

14. Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland;

15. Département de Pathologie, Hôpital Henri-Mondor, Université Paris-Est, INSERM U955, Créteil, France;

16. Division of Medical Oncology, National Cancer Centre Singapore/Duke–National University of Singapore (NUS) Medical School, Singapore;

17. Department of Pathology, Cleveland Clinic, Cleveland, OH;

18. Department of Pathology, City of Hope National Medical Center, Duarte, CA;

19. Hematopathology Unit, Hospital Clinic, Barcelona, Spain;

20. Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain;

21. Laboratory of Pathology and

22. Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;

23. Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ; and

24. Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE

Abstract

One-third of peripheral T-cell lymphomas are “not otherwise specified” (PTCL-NOS), but they have been subdivided into 2 subgroups based on gene expression profiling. Amador and colleagues generated an immunohistochemical algorithm that parallels the molecular separation of PTCL-NOS and provides useful prognostic information.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/134/24/2159/1547454/bloodbld2019000779.pdf

Reference42 articles.

1. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project;Rüdiger;Ann Oncol,2002

2. T-cell lymphomas in South America and Europe;Bellei;Rev Bras Hematol Hemoter,2012

3. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview;Sabattini;Pathologica,2010

4. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose;J Clin Oncol,2008

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next Questions in Peripheral T-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature;Diagnostic Pathology;2024-08-16

3. Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues;Modern Pathology;2024-08

4. Oral manifestations of peripheral T cell lymphoma, not otherwise specified: case series and review of the current literature;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-08

5. Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T‐cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypes;International Journal of Laboratory Hematology;2024-06-14